• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型冠状病毒肺炎感染的免疫球蛋白治疗：需谨慎！

Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!

机构信息

Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.

Division of Immunology, Boston Children's Hospital, Boston, MA, United States of America.

出版信息

Clin Immunol. 2020 Jul;216:108459. doi: 10.1016/j.clim.2020.108459. Epub 2020 May 11.

DOI:10.1016/j.clim.2020.108459
PMID:32418917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7211658/
Abstract

The COVID-19 pandemic is one of the greatest infectious challenges in recent history. Presently, few treatment options exist and the availability of effective vaccines is at least one year away. There is an urgent need to find currently available, effective therapies in the treatment of patients with COVID-19 infection. In this review, we compare and contrast the use of intravenous immunoglobulin and hyperimmune globulin in the treatment of COVID-19 infection.

摘要

COVID-19 大流行是近代历史上最严重的传染病挑战之一。目前，治疗方法有限，有效的疫苗至少要一年后才能问世。因此，迫切需要在治疗 COVID-19 感染患者方面找到现有的有效疗法。在这篇综述中，我们比较和对比了静脉注射免疫球蛋白和高免疫球蛋白在 COVID-19 感染治疗中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b06/7211658/54eb066f1a52/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b06/7211658/54eb066f1a52/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b06/7211658/54eb066f1a52/gr1_lrg.jpg

相似文献

1
Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution!新型冠状病毒肺炎感染的免疫球蛋白治疗：需谨慎！
Clin Immunol. 2020 Jul;216:108459. doi: 10.1016/j.clim.2020.108459. Epub 2020 May 11.
2
Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.用雷帕霉素靶向T细胞衰老和细胞因子风暴以预防COVID-19的严重进展。
Clin Immunol. 2020 Jul;216:108464. doi: 10.1016/j.clim.2020.108464. Epub 2020 May 13.
3
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.COVID-19 中的免疫反应：通过靶向 SARS-CoV-2 触发的途径来应对药理学挑战。
Signal Transduct Target Ther. 2020 May 29;5(1):84. doi: 10.1038/s41392-020-0191-1.
4
SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells.严重急性呼吸综合征冠状病毒 2 感染和 Nlrp3 炎性小体过度激活作为细胞因子“风暴”的触发因素和造血干细胞损伤的危险因素。
Leukemia. 2020 Jul;34(7):1726-1729. doi: 10.1038/s41375-020-0887-9. Epub 2020 Jun 1.
5
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.主动疗法联合被动免疫疗法可能对对抗新冠病毒有效。
Clin Transl Sci. 2020 Sep;13(5):835-837. doi: 10.1111/cts.12816. Epub 2020 Jun 26.
6
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.新型冠状病毒肺炎、肺肥大细胞、细胞因子风暴以及木犀草素的有益作用
Biofactors. 2020 May;46(3):306-308. doi: 10.1002/biof.1633. Epub 2020 Apr 27.
7
Scientific research progress of COVID-19/SARS-CoV-2 in the first five months.COVID-19/SARS-CoV-2 在头五个月的科学研究进展。
J Cell Mol Med. 2020 Jun;24(12):6558-6570. doi: 10.1111/jcmm.15364. Epub 2020 May 7.
8
Overview of lethal human coronaviruses.致死性人类冠状病毒概述。
Signal Transduct Target Ther. 2020 Jun 10;5(1):89. doi: 10.1038/s41392-020-0190-2.
9
COVID-19 Vaccine: A comprehensive status report.新型冠状病毒肺炎疫苗：全面现状报告。
Virus Res. 2020 Oct 15;288:198114. doi: 10.1016/j.virusres.2020.198114. Epub 2020 Aug 13.
10
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.关于新型冠状病毒 SARS-CoV-2 的结构和修复方面的研究进展。
Curr Top Med Chem. 2020;20(26):2362-2378. doi: 10.2174/1568026620666200922112300.

引用本文的文献

1
Toward understanding sexual immune dimorphism in humans.迈向理解人类的性免疫二态性。
Front Immunol. 2025 Jun 20;16:1570565. doi: 10.3389/fimmu.2025.1570565. eCollection 2025.
2
Antibody-dependent enhancement of coronaviruses.冠状病毒的抗体依赖性增强作用。
Int J Biol Sci. 2025 Feb 3;21(4):1686-1704. doi: 10.7150/ijbs.96112. eCollection 2025.
3
Dry powder formulations of hyperimmune serum.高免疫血清干粉制剂

本文引用的文献

1
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎（COVID-19）患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
2
Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development.乙肝表面抗原血清学清除：免疫机制、临床影响、对药物开发的重要性。
J Hepatol. 2020 Aug;73(2):409-422. doi: 10.1016/j.jhep.2020.04.013. Epub 2020 Apr 22.
3
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019.
Drug Deliv Transl Res. 2025 Apr;15(4):1330-1341. doi: 10.1007/s13346-024-01678-8. Epub 2024 Jul 31.
4
Blood-derived product therapies for SARS-CoV-2 infection and long COVID.用于治疗SARS-CoV-2感染和长期新冠的血液衍生产品疗法。
MedComm (2020). 2023 Nov 15;4(6):e426. doi: 10.1002/mco2.426. eCollection 2023 Dec.
5
COMMON VARIABLE IMMUNODEFICIENCY: PREDISPOSING OR PROTECTIVE FACTOR FOR SEVERE COMPLICATIONS OF COVID-19?常见可变免疫缺陷：是 COVID-19 严重并发症的诱发因素还是保护因素？
Acta Clin Croat. 2022 Mar;61(1):107-114. doi: 10.20471/acc.2022.61.01.13.
6
Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study.2021 年 2 月至 3 月，在迪拜一家三级保健医院，使用恢复期血浆治疗处于 COVID-19 感染早期阶段的孕妇：病例系列研究。
BMC Pregnancy Childbirth. 2022 Sep 25;22(1):730. doi: 10.1186/s12884-022-05043-w.
7
Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review.用于管理 COVID-19 危重症患者的免疫调节治疗：一项叙述性综述。
World J Crit Care Med. 2022 Jul 9;11(4):269-297. doi: 10.5492/wjccm.v11.i4.269.
8
Prescribing Practices of Intravenous Immunoglobulin in Tertiary Care Hospitals in Malaysia: A Need for a National Guideline for Immunoglobulin Use.马来西亚三级护理医院静脉注射免疫球蛋白的处方实践：需要制定免疫球蛋白使用的国家指南。
Front Pharmacol. 2022 Jun 9;13:879287. doi: 10.3389/fphar.2022.879287. eCollection 2022.
9
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.新型冠状病毒肺炎被动免疫治疗的最新进展：基于证据的方法和临床试验。
Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21.
10
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.针对 SARS-CoV-2 的被动免疫疗法：从基于血浆的疗法到单一强效抗体，以在与变异体的竞赛中保持领先地位。
BioDrugs. 2022 May;36(3):231-323. doi: 10.1007/s40259-022-00529-7. Epub 2022 Apr 27.
大剂量静脉注射免疫球蛋白作为新型冠状病毒肺炎病情恶化患者的一种治疗选择
Open Forum Infect Dis. 2020 Mar 21;7(3):ofaa102. doi: 10.1093/ofid/ofaa102. eCollection 2020 Mar.
4
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征：一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
5
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸系统综合征冠状病毒 2 刺突糖蛋白的结构、功能和抗原性。
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.
6
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.COVID-19 的免疫反应和潜在疫苗：从 SARS 和 MERS 疫情中吸取的教训。
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.
7
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.抗体依赖增强作用促进冠状病毒进入的分子机制。
J Virol. 2020 Feb 14;94(5). doi: 10.1128/JVI.02015-19.
8
Effect of recent seasonal influenza vaccination on serum antibody responses to candidate pandemic influenza A/H5N1 vaccines: A meta-analysis.近期季节性流感疫苗接种对候选大流行性流感 A/H5N1 疫苗血清抗体应答的影响：一项荟萃分析。
Vaccine. 2019 Sep 3;37(37):5535-5543. doi: 10.1016/j.vaccine.2019.04.066. Epub 2019 May 31.
9
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.抗刺突 IgG 通过在急性 SARS-CoV 感染期间使巨噬细胞反应发生偏斜，导致严重的急性肺损伤。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.123158.
10
Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis.二价和四价人乳头瘤病毒疫苗诱导的非疫苗所含基因型血清阳性反应：一项系统评价和荟萃分析。
Vaccine. 2017 Jul 13;35(32):3922-3929. doi: 10.1016/j.vaccine.2017.06.028. Epub 2017 Jun 17.